He showed me around, showed me the beads, explained the analyzer technology in more detail. I saw and was intoduced to two scientist, I saw someone else in another office and including Dr. G, I saw 4 people and he said there were 5 scientist (not including himself). I only saw one lab, and there was other labs I did not enter, so maybe the others were there (?) It's larger in their then what it looks from outside. The 2 scientist I met looked fairly happy, the work environment and their demeanor seemed enthusiastic . This looks optimistic to me. Many investors/ analyst actually visit companies they invest, it's there due diligance. I happen to be in the Toronto area and I took this opportunity. In fact, if they have an annual meeting open to investors, I will attend.

You ask why is it taking so long ? That is a good question and mine as well, and I do share your fustration on lack of reporting. At this point, what I paid for the shares is much higher than current SP and I knew it was a risk when I bought the shares. Hopefully the clinical trial will be a success.